Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients

BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19–related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccicacco, Nicholas, Zeitler, Kristen, Montero, Jose, Kumar, Ambuj, Lakshmi, Seetha, Kim, Kami, Wein, David, Vasey, Tiffany, Vasey, Matthew, Oxner, Asa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195104/
https://www.ncbi.nlm.nih.gov/pubmed/34258319
http://dx.doi.org/10.1093/ofid/ofab292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195104/
https://www.ncbi.nlm.nih.gov/pubmed/34258319
http://dx.doi.org/10.1093/ofid/ofab292

Ejemplares similares